Adlai Nortye (STU:N2U0) FCF Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Adlai Nortye's Free Cash Flow for the three months ended in Jun. 2023 was €-7.73 Mil. Adlai Nortye's Revenue for the three months ended in Jun. 2023 was €0.00 Mil. Therefore, Adlai Nortye's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

As of today, Adlai Nortye's current FCF Yield % is -14.35%.

The historical rank and industry rank for Adlai Nortye's FCF Margin % or its related term are showing as below:

STU:N2U0' s FCF Margin % Range Over the Past 10 Years
Min: -1137.04 Med: -573.06 Max: -9.08
Current: -373

During the past 3 years, the highest FCF Margin % of Adlai Nortye was -9.08%. The lowest was -1137.04%. And the median was -573.06%.

STU:N2U0's FCF Margin % is ranked worse than
63.46% of 1040 companies
in the Biotechnology industry
Industry Median: -137.43 vs STU:N2U0: -373.00

Adlai Nortye FCF Margin % Historical Data

The historical data trend for Adlai Nortye's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye FCF Margin % Chart

Adlai Nortye Annual Data

Trend

Dec21

Dec22

Dec23

FCF Margin %

-9.08

-1,137.03

Adlai Nortye Quarterly Data
	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Adlai Nortye's FCF Margin %

For the Biotechnology subindustry, Adlai Nortye's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adlai Nortye's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adlai Nortye's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Adlai Nortye's FCF Margin % falls into.

Adlai Nortye FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Adlai Nortye's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-52.133	/	4.585
	=	-1,137.03 %

Adlai Nortye's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-7.734	/	0
	=	%

Adlai Nortye FCF Margin % Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Adlai Nortye (STU:N2U0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (STU:N2U0) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

ANL:USA

Address

685 US Highway 1, North Brunswick, NJ, USA, 08902

Website

https://www.adlainortye.com

Adlai Nortye Ltd is a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types. The company has robust pipeline of drug candidates it includes buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as four preclinical candidates.

Adlai Nortye (STU:N2U0) Headlines

No Headlines